company and its subsidiaries financial statement for the fiscal year 2015, ended as of December 31, 2015 which details are as following; Results 2015 (Revised Version) 2014 (Revised Version) Increase

year, due to the delay approval process of budget expenditure of the government for the 2020 fiscal year. - Revenues from sales and beauty treatment services in Q2/2020 were THB 4 million decreased by 92

Offering of Debt Securities by Foreign Issuer Commercial Name of the Issuer……………………………………….. Offering to…………………………………………………………………….. Features of Debt Securities i.e. interest rate/ offering unit /total

%. The unemployment rate in 1Q/2024 was 1.01%. However, the K-shape recovery causes household debt (seasonal adjusted) to continue climbing up from 90.7% in the 1Q/2023 to 91.4% in 1Q/2024. For the 1Q/2024

debt. As of November 30, 2020, the Company’s total cards reached 9.11 million cards, including 2.91 million credit cards, and 6.20 million-member cards. The Company has active customers more than 2

Turnover Ratio Settlement Period: Sharpe Ratio Alpha Remark: ……………………………………...………………….……. ………………………………………………………………………… ………………………………………………………………………… Beta Tracking Error Average Maturity of Debt Instruments

Ratio Alpha Remark: ……………………………………...………………….……. ………………………………………………………………………… ………………………………………………………………………… Beta Tracking Error Average Maturity of Debt Instruments Fees to be charged to the fund (% of NAV

Error Average Maturity of Debt Instruments Fees to be charged to the fund (% of NAV per annum) Yield to Maturity Country Allocation Fee items Maximum charge Actual charge Management fee Total expenses

IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited

, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like